Big pharma experts join forces to drive automation of data workflow
Leaders from some of the industry’s most notable companies are working together to streamline and automate IDMP workflow and come up with various standards.
Leaders from some of the industry’s most notable companies are working together to streamline and automate IDMP workflow and come up with various standards.
The Australian biotechnology company has been granted ODD status from the agency for Veyonda, a therapy intended for the treatment of soft-tissue sarcoma.
Novartis has created a new organizational structure and operating model: which it says will make the company more agile and competitive.